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Abstract
Phage lysin was evaluated as a substitute for antibiotics in sputum samples processed by a modiﬁed Petroff’s method for the detection
of Mycobacterium tuberculosis with the MGIT 960 system. One hundred and ﬁfty sputum samples were processed, inoculated onto two
slopes of Lowenstein–Jensen medium, and divided in to two aliquots of 0.5 mL each. One aliquot was added to 7 mL of MGIT medium
containing polymyxin B, amphotericin B, nalidixic acid, trimethoprim and azlocillin (PANTA) (MGIT-PANTA) and the other was added
to 7 mL of MGIT medium containing 0.8 mL of lysin (MGIT-Lysin). The samples were randomized and incubated at 37C in the
MGIT 960 system. The sensitivity and speciﬁcity of MGIT-Lysin were 97% and 88%, respectively, as compared with MGIT-PANTA. The
average times to detection with MGIT-Lysin and MGIT-PANTA were 9.3 and 8.6 days, respectively. The rate of contamination with
MGIT-PANTA and MGIT-Lysin were 16% and 7.3%, respectively. Phage lysin can be substituted for antibiotics in processed sputum sam-
ples for the detection of M. tuberculosis.
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Introduction
Primary isolation of Mycobacterium tuberculosis from sputum
samples, on either solid or liquid media, and identiﬁcation
of the drug sensitivity pattern is essential for determination
of the disease status of a patient. Overgrowth of normal
ﬂora escaping the action of the sputum-processing agent is
a major problem that affects the sensitivity of any rapid
assay [1]. Combinations of antibiotics, in the form of either
polymyxin B, amphotericin B, nalidixic acid, trimethoprim
and azlocillin (PANTA) or polymyxin B, amphotericin B,
carbenicillin and trimethoprim (PACT), and other com-
pounds are incorporated into the media used for the pri-
mary isolation of tubercle bacilli to minimize the risk of
non-mycobacterial contamination. However, it is recom-
mended that the exposure of primary isolates to these anti-
biotics should be limited, as these agents affect the long-
term growth of mycobacteria [2].
The use of cocktails of phages as phagebiotics substituting
for antibiotics to control the overgrowth of normal ﬂora in
processed sputum samples has been demonstrated [2]. This
constitutes a novel, non-chemical and bio-friendly approach
to tackle the problem of non-mycobacterial contaminants.
Phage-based enzyme, lysin, was also added to phagebiotics
for the effective control of normal ﬂora. The combination of
phagebiotics with lysin and lysin alone were found to be
efﬁcient and comparable for control of the overgrowth of
normal ﬂora without hampering the viability of M. tuberculosis
[3].
In the present study, phage lysin was evaluated for decon-
tamination of processed sputum samples in comparison with
PANTA for the primary isolation of M. tuberculosis with the
BACTEC MGIT 960 system. In addition, lysin was evaluated
in comparison with PANTA for the growth and retrieval of
M. tuberculosis with Lowenstein–Jensen (LJ) medium.
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Materials and Methods
Preparation of phage lysin
Phage lysin was prepared individually from phages Che-
dec 11, Chedec 20 and Chedec 21, as described previously
[3]. These phage lysins were dissolved in albumin dextrose
complex (4 g of D-glucose, 0.85 g of NaCl and 10 g of bovine
serum albumin in 100 mL of distilled water) at its ﬁnal stage
of preparation, and pooled prior to use.
Effect of lysin on the growth of M. tuberculosis
One hundred and twenty sputum samples were collected
from patients attending the Tuberculosis Research Centre,
Chennai, and processed by modiﬁed Petroff’s method. Two
LJ slopes were inoculated from the processed deposits and
used as controls. The deposits were washed with 0.067 M
phosphate-buffered saline at pH 6.8, and divided into two
aliquots of 0.5 mL each. To one aliquot, 0.5 mL of PANTA
was added by mixing 0.1 mL of PANTA in 0.4 mL of 7H9
medium supplemented with 0.5% glycerol and 10% albumin
dextrose complex (G7H9) (7H9-PANTA). To the other
aliquot, 0.5 mL of lysin was added by mixing 0.1 mL of
pooled lysin in 0.4 mL of G7H9 (7H9-Lysin). The aliquots
were randomized and incubated at 37C for 18–24 h. Two
more LJ slopes were inoculated from all of the aliquots and
incubated. The LJ slopes were read every week up to
8 weeks. The results were compared after decoding.
Evaluation of lysin for the decontamination of sputum
samples
A total of 150 sputum samples were collected from patients
attending the Tuberculosis Research Centre, Chennai;
smears prepared from these samples were stained by the
auromine phenol staining method. The samples were pro-
cessed by modiﬁed Petroff’s method. Two LJ slopes were
inoculated from the deposits thus obtained, and incubated at
37C for up to 8 weeks. The deposits were washed with
phosphate-buffered saline and divided into two aliquots of
0.5 mL each. One aliquot was added to a MGIT tube con-
taining 7 mL of medium and 0.8 mL of PANTA (MGIT-
PANTA). Another aliquot was added to a MGIT tube
containing 7 mL of medium and 0.8 mL of pooled lysin
(MGIT-Lysin). The tubes were randomized and kept in the
MGIT 960 instrument. Further readings and conﬁrmation of
the presence of tubercle bacilli were performed according to
the manufacturer’s protocol. The results were compared
after decoding.
Statistical analysis
The test of signiﬁcance was calculated with Fisher’s exact
test, using SPSS software version 14.
Results
Effect of lysin on the growth of M. tuberculosis
The sensitivity and speciﬁcity of 7H9-PANTA were 91% and
94%, respectively, and the sensitivity and speciﬁcity of 7H9-
Lysin were 92% and 91%, respectively, as compared with
modiﬁed Petroff’s culture as the reference standard (Table
1a,b). The sensitivity and speciﬁcity of 7H9-Lysin were 98%
and 91%, respectively, as compared with 7H9-PANTA. The
agreement between the methods was 94% (Table 1c). None
of these samples was found to be contaminated when trea-
ted with either lysin or PANTA and incubated overnight at
37C. Only three samples were contaminated by conven-
tional culture, and were excluded from the comparison.
Evaluation of lysin for decontamination of sputum samples
Of the 150 sputum samples collected, 103 were positive
(69%) and 47 were negative (31%) by smear with the auro-
mine phenol staining method. Modiﬁed Petroff’s culture
showed growth of M. tuberculosis in 83 (55.3%) samples, and
TABLE 1. Effect of polymyxin B, amphotericin B, nalidixic acid, trimethoprim and azlocillin (PANTA) and phage lysin on the
growth of Mycobacterium tuberculosis
a b c
Petroff’s culture Petroff’s culture 7H9-PANTA
Pos Neg Total Pos Neg Total Pos Neg Total
7H9-PANTA Pos 48 4 52 7H9-Lysin Pos 49 6 55 7H9-Lysin Pos 51 6 57
Neg 5 60 65 Neg 4 58 62 Neg 1 62 63
Total 53 64 117 Total 53 64 117 Total 52 68 120
Sensitivity, 91%; speciﬁcity, 94%; agreement, 92%; PPV,
92%; NPV, 92%
Sensitivity, 92%; speciﬁcity, 91%; agreement,
91%; PPV, 89%; NPV, 94%
Sensitivity, 98%; speciﬁcity, 91%; agreement,
94%; PPV, 89%; NPV, 98%
Pos, positive; Neg, negative; PPV, positive predictive value; NPV, negative predictive value.
Sputum samples were processed with a modiﬁed Petroff method, and two Lowenstein–Jensen (LJ) slopes were inoculated (Petroff’s culture). The sputum deposits were
divided into two: to one aliquot, Middlebrook 7H9 medium containing PANTA (7H9-PANTA) was added, and this was used as a control. To the other aliquot, 0.5 mL of
Middlebrook 7H9 medium containing phage lysin (7H9-Lysin) was added; this was incubated overnight and inoculated onto two LJ slopes.
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no growth in 66 (44%) samples; the remaining sample was
contaminated (0.7%). The sensitivity of MGIT-PANTA and
MGIT-Lysin was 100%, and the speciﬁcities were 74% and
73%, respectively, as compared with conventional culture
(Table 2a,b). The sensitivity and speciﬁcity of MGIT-Lysin
were 97% and 88%, respectively, as compared with MGIT-
PANTA as the reference standard. The agreement between
the methods was 94% (Table 2c). The average times to
detection for MGIT-Lysin and MGIT-PANTA were 9.3 and
8.6 days, respectively, as compared with conventional culture
(Table 3). The rates of contamination were 16% with MGIT-
PANTA and 7.3% with MGIT-Lysin. The samples that
showed contamination with either of the methods were
excluded from the comparison.
Among 66 culture-negative samples, 14 were positive
(21%) by MGIT-PANTA, with a mean time to detection
(TTD) of 12.8 days. Of the remaining 52 samples, 35 were
negative (53%) and 17 were contaminated (26%). Of the
samples treated with phage lysin (MGIT-Lysin), 17 were posi-
tive (26%), with a mean TTD of 15.8 days, 40 were negative
(61%), and only nine were contaminated (13%). Among 83
culture-positive samples, 14 grew few colonies, and 22, 33
and 14 resulted in growth graded as 1+, 2+ and 3+, respec-
tively, on LJ medium. When PANTA was used (MGIT-
PANTA) for the detection of tubercle bacilli, 77 samples
were positive and the remaining six samples were contami-
nated. Similarly, when phage lysin was used (MGIT-Lysin), 82
samples were positive and only one sample was contami-
nated. None of the samples positive on LJ medium was
missed by both MGIT-PANTA and MGIT-Lysin, resulting in a
sensitivity of 100%. The sample that was contaminated by LJ
was also contaminated by both MGIT-PANTA and MGIT-
Lysin (Table 4).
Statistical analysis
Sputum samples processed and treated with phage lysin for
the detection of M. tuberculosis with the MGIT 960 system
TABLE 2. Comparison of MGIT-PANTA and MGIT-Lysin for the detection of Mycobacterium tuberculosis with the MGIT 960
system
a b c
Petroff’s culture Petroff’s culture MGIT-PANTA
Pos Neg Total Pos Neg Total Pos Neg Total
MGIT-PANTA Pos 79 12 91 MGIT-Lysin Pos 84 15 99 MGIT-Lysin Pos 88 4 92
Neg 0 35 35 Neg 0 40 40 Neg 3 28 31
Total 79 47 126 Total 84 55 139 Total 91 32 123
Sensitivity, 100%; speciﬁcity, 74%; agreement,
90%; PPV, 87%; NPV, 100%
Sensitivity, 100%; speciﬁcity, 73%; agreement,
89%; PPV, 85%; NPV, 100%
Sensitivity, 97%; speciﬁcity, 88%; agreement, 94%;
PPV, 96%; NPV, 90%
PANTA, polymyxin B, amphotericin B, nalidixic acid, trimethoprim and azlocillin; Pos, positive; Neg, negative; PPV, positive predictive value; NPV, negative predictive value.
Sputum samples were processed with a modiﬁed Petroff method, and two Lowenstein–Jensen slopes were inoculated (Petroff’s culture). The sputum deposits were divided
into two: one aliquot was added to MGIT tubes containing PANTA (MGIT-PANTA) and used as a control. The other aliquot was added to MGIT tubes containing phage lysin
(MGIT-Lysin) and incubated in the MGIT system.
TABLE 3. Average time to detection (days) for MGIT-
PANTA and MGIT-Lysin
Grade
Smear Culture
PANTA Lysin PANTA Lysin
Negative 11.5 (3–38) 12.4 (3-39) 12.8 (2–39) 15.8 (4–27)
Colonies NA NA 10.0 (2–19) 10.4 (2–14)
1+ 9.1 (3–29) 9.8 (2– 27) 9.3 (1–17) 9.0 (1–22)
2+ 6.5 (2–12) 6.6 (3–14) 6.0 (2–12) 6.0 (1–12)
3+ 5.9 (1–8) 6.2 (3–9) 5.0 (2–7) 5.4 (2–10)
Average 8.3 8.8 8.6 9.3
PANTA, polymyxin B, amphotericin B, nalidixic acid, trimethoprim and azlocillin;
NA, not applicable.
Ranges are given in parentheses.
TABLE 4. Overall performance of MGIT-PANTA and MGIT-Lysin for the detection of Mycobacterium tuberculosis with the
MGIT 960 system
Culture grade
(no. of samples)
MGIT-PANTA MGIT-Lysin
Positives
(TTD) in days Negatives Contamination
Positives
(TTD) in days Negatives Contamination
Negatives (66) 14 (12.8) 35 17 17 (15.8) 40 9
Colonies (14) 11 (10.0) 0 3 14 (10.4) 0 0
1+ (22) 21 (9.3) 0 1 22 (9.0) 0 0
2+ (33) 31 (6.0) 0 2 32 (6.0) 0 1
3+ (14) 14 (5.0) 0 0 14 (5.4) 0 0
Contamination (1) 0 0 1 0 0 1
Total (150) 91 35 24 99 40 11
150 150
PANTA, polymyxin B, amphotericin B, nalidixic acid, trimethoprim and azlocillin; TTD, time to detection.
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showed signiﬁcance as compared with samples treated with
PANTA. Fisher’s exact test showed a value of 0.000.
Discussion
The mechanical pressure and the chemical pressure induced
when sputum specimens are processed with either a strong
alkali such as 4% NaOH (Petroff’s method) or a combination
of N-acetyl-L-cysteine (NALC) and 2% NaOH (NALC-
NaOH method) leave the tubercle bacilli in the sputum
unsuitable for any rapid assay, especially for phage-based
assays [2]. Sputum specimens have inherent features that
hamper the detection of viable tubercle bacilli, resulting in
difﬁculties in rapid tuberculosis diagnosis [4]. The main prob-
lem is caused by the normal ﬂora present in the sputum
specimens, and problems are also caused by mucous strands,
enzymes and other inhibitory factors, and the remains of
chemicals used in sputum processing. The normal ﬂora
escaping the action of sputum processing chemicals tend to
overgrow and mask the growth of tubercle bacilli, leading to
poor sensitivity in detecting M. tuberculosis. Contamination in
liquid-based detection systems by particular bacteria or fungi
reﬂects the presence of these microorganisms in the speci-
mens received for culture and the ability of these organisms
to survive decontamination processes [5]. The most com-
mon organisms causing contamination are from respiratory
sources (Bacillus, Staphylococcus, Micrococcus, Pseudomonas,
coagulase-negative staphylococci and Corynebacterium). In
some studies, the presence of yeast and moulds has also
been reported.
The BACTEC system for direct susceptibility testing in
clinical laboratories did not ﬁnd practical application, for four
main reasons: ‘unknown effect of ﬁve antibiotics (PANTA)
added to prevent the growth of contaminants, on the activity
of the tested agent’ is one reason among the four [6]. There
have been reports of PANTA added to suppress the growth
of contaminating bacteria in the MGIT 960 system having
some inhibitory effect on some mycobacteria other than
M. tuberculosis complex [7]. This inhibition varies from spe-
cies to species and between isolates within a species.
PANTA has been replaced by a combination of vancomycin,
amphotericin B and nalidixic acid to minimize the rate of
contamination in the MGIT 960 system without reducing
mycobacterial recovery. However, vancomycin itself has a
bactericidal effect on some mycobacteria, such as Mycobacte-
rium fortuitum, Mycobacterium senegalense, Mycobacterium septi-
cum and unidentiﬁed strains of mycobacteria [8].
Inhibitory effects of PANTA on the growth of Mycobac-
terium genavense and Mycobacterium kansasii in BACTEC
primary cultures have been reported. Preliminary experi-
ments showed that polymyxin B and azlocillin exerted some
growth inhibition on M. genavense [9], and nalidixic acid had
an inhibitory effect on the growth of M. kansasii [10]. In the
selective antibiotic combination PACT, carbenicillin has been
reported to have potentially inhibitory effects on mycobacte-
ria [11]. Furthermore, it has also been reported that PACT
used in the MB Redox tube method reduces mycobacterial
growth in specimens collected from sterile body sites [12]. As
an alternative to combinations of antibiotics, phage lysin was
used in the present study to control the overgrowth of nor-
mal ﬂora without compromising the viability of M. tuberculosis.
Inclusion of a liquid medium for primary isolation and
identiﬁcation of M. tuberculosis has been recommended [13].
Conventional solid culture with either LJ medium or 7H11
agar medium is the reference standard. In the 1990s, the
radiometric semi-automated BACTEC 460TB system was
the liquid-based detection method that was most widely
used for mycobacteria, and was universally accepted as the
reference standard for liquid medium [14]. Owing to the
presence of radiolabelled carbon in the medium and semi-
automation, the BACTEC 460 system was replaced by the
non-radiometric, fully automated MGIT 960 system. The
MGIT 960 system has been evaluated and is considered to
be a valuable alternative to the BACTEC 460 system [15].
However, a higher rate of contamination was reported for
the MGIT 960 system than for the BACTEC 460 system
[16]. The higher contamination rate was attributed to the
presence of rich protein i.e. albumin dextrose catalase in
MGIT 960 medium [14], the percentage of NaOH used to
decontaminate sputum samples [17], and climatic conditions
and delays in transport of samples to the laboratory [18].
The high contamination rate with the MGIT 960 system
resulted in a lower recovery rate of M. tuberculosis [19].
The average TTD for the MGIT 960 system was reported
to range between 8.5 and 13.3 days. In this study, the aver-
age TTDs for both MGIT-Lysin (9 days) and MGIT-PANTA
(8 days) were found to be low (Table 3). In 2009, Rodrigues
et al. [16] reported TTDs of 7, 8, 11 and 16 days for samples
with 3+, 2+, 1+ and negative smear grades, respectively. In
the present study, average TTDs were 5, 6, 9 and 11 days
for the detection of M. tuberculosis from samples with smear
grades of 3+, 2+, 1+ and negative, respectively.
A slight increase was noted in the average TTD for
MGIT-Lysin as compared with MGIT-PANTA. The difference
was found to be not signiﬁcant by t-test (p 0.84). An
in-house preparation of albumin dextrose complex was used
for MGIT-Lysin, whereas a growth supplement containing
oleic acid was used for MGIT-PANTA. The difference in
growth supplement may be attributed to the increased
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average TTD for MGIT-Lysin. Of the samples treated with
MGIT-PANTA and MGIT-Lysin, 24 (16%) and 11 (7.3%),
respectively, showed overgrowth of normal ﬂora, and eight
samples showed growth with both. Three samples that
resulted in overgrowth of normal ﬂora only in MGIT-Lysin
were negative in MGIT-PANTA, and among 16 samples that
resulted in overgrowth of normal ﬂora only in MGIT-
PANTA, six samples were positive and the rest were nega-
tive in MGIT-Lysin. Phage lysin used to control overgrowth
of normal ﬂora in processed sputum samples signiﬁcantly
increased the rate of recovery of M. tuberculosis and
decreased the rate of contamination as compared with the
use of a combination of antibiotics, i.e. PANTA, without
hampering the viability of M. tuberculosis.
The approach of utilizing bacteriophages and their lysin to
control the overgrowth of normal ﬂora in processed sputum
samples have been ﬁled for patenting through the Intellectual
Property Rights Unit of the Indian Council of Medical
Research (File No. 2819/DEL/2008). Sequencing of bacterio-
phages Chedec 11, Chedec 20 and Chedec 21 has been initi-
ated. Furthermore, on the basis of the genome sequence,
phage lysins of these phages will be identiﬁed, characterized
and puriﬁed to favour the bulk production of lysins by
genetic engineering. Accordingly, the cost-effectiveness of
lysin preparation will be calculated in comparison with
PANTA, and a multicentre evaluation will be performed to
assess the efﬁcacy of phage lysins in decontaminating pro-
cessed sputum samples.
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